首页> 外国专利> A Derivative of 2 - - - pirimidinil 6,7,8,9 tetrahidropirimido 1,2-a - pyrimidine - 4 and 7 - pirimidinil ONA - 2.3 - dihidroimidazo 1,2-a pyrimidine 5 (1H) Ona replaced, use, which comprises a Medicine and an inhibitor of GSK3beta or GSK3beta and selected between Cdk5 / P25 the group of the derivative

A Derivative of 2 - - - pirimidinil 6,7,8,9 tetrahidropirimido 1,2-a - pyrimidine - 4 and 7 - pirimidinil ONA - 2.3 - dihidroimidazo 1,2-a pyrimidine 5 (1H) Ona replaced, use, which comprises a Medicine and an inhibitor of GSK3beta or GSK3beta and selected between Cdk5 / P25 the group of the derivative

机译:取代了2--吡咪啶6,7,8,9四氢吡啶亚胺基[1,2-a]-嘧啶-4和7-吡咪啶ONA-2.3-二氢咪唑并[1,2-a]嘧啶5(1H) ,用途,其包含药物和GSK3beta或GSK3beta抑制剂,并选自Cdk5 // P25之间的衍生物

摘要

Primidone derivative represented by the formula (1) or a Salt thereof, or a solvate thereof, or a hydrate thereof, where X represents two Hydrogen Atoms and one Sulfur Atom, an oxygen Atom or a c1-2 alkyl group and a hydrogen Atom; and represents a Union, a gru Etenileno etinileno po, a Group, an oxygen Atom and a Sulfur Atom, a sulfonyl Group,A sulfoxide Group, a carbonyl Group, a nitrogen Atom, an optionally substituted by alkyl group C1 - 6, a phenyl or benzyl Group; or a methylene Group optionally substituted by one or two groups selected from an alkyl group C1 - 6, a benzyl Group, a hydroxyl Group, a gr Upo c1-4 alkoxy, a cicloalquil - C3 - 6 metiloxi Group, an alkyl group perhalogenado c1-2,An amino Group, a group or a phenyl Group acetyl amino pyrimidine Ring; r1 represents an optionally substituted cycloalkyl C3 6 by a group or a c1-4 alkyl group, alkoxy Group C1 - 4 a benzyl Group, or a Halogen Atom; and represents a Union, a methylene Group is optional Mind or a substituted carbonyl GroupThen R2 represents an alkyl group, an optionally substituted C1 - C6 ariloxi 6 - 10 or a group arilamino C6 - 10 pp. ISBN a cycloalkyl Group; 6, a group Alquiltio c1-4 alkoxy Group, a c1-4 alkyl group, a perhalogenado c1-2 alkyl group, a Halogenated C1 - 3, a group phenylthio Group, a benzyl Or, a phenyl ring, a Ring of a ring indanilo, 5,6,7,8-tetrahydro - naphthyl,Naphthyl ring, pyridine ring, a Ring of a Ring of pyrrole, Furan or thiophene ring, an imidazole Ring; or where the benzyl Group optionally substituted rings are for 1 to 4 substituents selected from an alkyl group C1 - 6, a methylenedioxy Group, an Atom Halogen, alkyl group perhalogenado c1-2 alkyl group, a Halogenated C1 - 3A hydroxyl Group, a Group a c1-4 alkoxy, Nitro, cyano, amino, a Group monoalquilamino C1 - C2 - dialquilamino 5, a Group, a Group alquilcarbonil C1 - 6 - amino Group, an aryl carbonyl amino c6-10, a sulfonyl Group c1-4 alkyl, a sulfoniloxi c1-4 alkyl group or a phenyl; and when the Div. A etenileno ATN Group, a Group etinileno, an oxygen Atom and a Sulfur Atom.A sulfonyl Group, a sulfoxide group or an optionally substituted nitrogen Atom, then R2 represents an alkyl group C1 - 6 (optionally replaced by a group ariloxi C1 - C6 Group arilamino 6 or 10), a cycloalkyl Group C3 - 6, a perhalogenado c1-2 alkyl group, an alkyl group Halogenated C1 - 3, a benzyl Group, a phenyl ring, a Ring of a ring indanilo, 5,6,7,8 - tetrahydro - naphthyl ring, naphthyl, a Pyridine ring, a Ring of a Ring of pyrrole, Furan or thiophene ring, an imidazole Ring; or where the benzyl Group optionally substituted rings are for 1 to 4 substituents selected from an alkyl group C1, Group M Ethylenedioxy, a Halogen Atom, an alkyl group perhalogenado c1-2,A Halogenated c1-3 alkyl group, a hydroxyl Group, a Group a c1-4 alkoxy, Nitro, cyano, amino, a Group monoalquilamino C1 - 5 - 10 dialquilamino C2 Group, an alkyl group, a C1 - 6 - amino carbonyl Group, an aryl carbonyl amino c6-10, a c1-4 alkyl sulfonyl Group, alkyl group sulfoniloxi C 1 - 4 or a phenyl Group; R3 and R4 represent each independently a hydrogen Atom,A C1 - 6 alkyl group, a Hydroxy Group, a group or a c1-4 alkoxy Halogen Atom; R5 represents a hydrogen Atom, an alkyl group C1 - 6 or a Halogen Atom; when M is equal to 0, p is equal to 1, 2 or 3; when M is equal to 1, p is equal to 0, 1 or 2; when M is equal to 2, P IG UAL is 0 OR 1; and N represents between 0 and 3.It also discloses a drug comprising the derivative or a Salt thereof as an active ingredient which is used for Therapeutic and / or prophylactic Treatment of a neurodegenerative disease caused by abnormal activity of GSK3beta or GSK3beta and Cdk5 / P25, such asAlzheimer's disease; or an inhibitor of GSK3beta GSK3beta and Cdk5 / P25 selected among the group of Primidone derivative represented by the formula (1) or salts thereof, or a solvate thereof, or a hydrate thereof; and the use of the Derivative of Primidone.
机译:由式(1)表示的Primidone衍生物或其盐,或其溶剂化物或水合物,其中X表示两个氢原子和一个硫原子,一个氧原子或一个c1-2烷基和一个氢原子;且表示一个并集,一个或多个Etenileno etinileno po,一个基团,一个氧原子和一个硫原子,磺酰基,亚砜基,羰基,氮原子,可选被烷基C1-6取代的苯基或苄基;或任选被一个或两个选自烷基C1-6的基团取代的亚甲基,苄基,羟基,gr Upo c1-4烷氧基,环庚烷基-C3-6甲硫醚基,全卤代烷基c1 -2,氨基,乙酰氨基嘧啶环的基团或苯基; r1表示被基团或c1-4烷基,烷氧基C1-4,苄基或卤素原子取代的环烷基C3 6。 R 2代表烷基,任选取代的C 1 -C 6芳基6-10或芳烃基C 6-10 pp.ISBN为环烷基;参照图6,Alquiltio c1-4烷氧基,c1-4烷基,全卤代c1-2烷基,卤代C1-3,苯硫基,苄基或,苯环,环的环茚满基洛,5,6,7,8-四氢-萘基,萘基环,吡啶环,吡咯,呋喃或噻吩环的环,咪唑环;或其中苄基任选取代的环是1-4个选自烷基C1-6的取代基,亚甲基二氧基,原子卤素,烷基全卤代的c1-2烷基,卤代的C1-3A羟基, c 1-4烷氧基,硝基,氰基,氨基,单al氨基C1-C2-二quil氨基5,基团、,基C1-6-氨基,芳基羰基氨基c6-10,磺酰基c1-4烷基,磺酰氯C 1-4烷基或苯基;而当分区。一个etenileno ATN基团,一个etinileno基团,一个氧原子和一个硫原子。一个磺酰基,一个亚砜基团或一个可选被取代的氮原子,然后R2代表一个烷基C1-6(可被芳基C1-C6取代)芳基氨基6或10),C3-6环烷基,C1-2卤代烷烃基,C1-3卤代烷基,苄基,苯环,茚满基环的环,5,6,7 ,8-四氢萘环,萘基,吡啶环,吡咯,呋喃或噻吩环的环,咪唑环;或其中苄基任选取代的环是1-4个选自以下的取代基:烷基C1,M族乙二氧基,卤原子,烷基全卤原子c1-2,卤代c1-3烷基,羟基, C 1-4基团烷氧基,硝基,氰基,氨基,单amino基氨基C1-5-10二dial基氨基C2基团,烷基,C1-6氨基羰基基团,芳基羰基氨基C6-10,C1-4基团烷基磺酰基,烷基磺酰基C 1-4或苯基; R3和R4分别独立地表示氢原子,C1-6烷基,羟基,羟基或C1-4烷氧基卤素原子。 R5代表氢原子,烷基C1-6或卤素原子;当M等于0时,p等于1、2或3;当M等于1时,p等于0、1或2;当M等于2时,P IG UAL为0或1; N表示0至3。还公开了包含该衍生物或其盐作为有效成分的药物,该药物用于治疗和/或预防性治疗由GSK3beta或GSK3beta和Cdk5的异常活性引起的神经变性疾病。 / P25,例如阿尔茨海默氏病;或选自式(1)表示的Primidone衍生物或其盐,或其溶剂化物或水合物的GSK3beta,GSK3beta和Cdk5 / P25的抑制剂。以及Primidone衍生物的使用。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号